Boston Scientific Corp. Stock Slides 5.8%, Underperforms Peers
Dow Jones2026/10/28 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Boston Scientific Corp. shed 5.8% to $42.43 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.3% to 7,743.98 and the Dow Jones Industrial Average rising 0.2% to 52,475.10.
This was the stock's fourth consecutive day of losses.
Boston Scientific Corp. closed 59.8% short of its 52-week high of $105.65, which the company achieved on November 13th.
The stock underperformed when compared to some of its peers, as Abbott Laboratories fell 0.4% to $102.64, Medtronic PLC rose 0.9% to $94.78, and Stryker Corp. rose 0.86% to $304.00.
Trading volume totaled 69.3 million, compared to the 50-day average of 18.7 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 28, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
2-Yr Benchmark Govt Yields - Germany vs Other Nations
AI demand accelerates and hits production capacity bottleneck! Citi: Storage supply shortage is far from over, maintains high rating on Micron Technology (MU.US) with target price of $1,300
Citi believes that as AI-driven demand from hyperscalers continues to accelerate, the market is underestimating the potential for ongoing tightness in DRAM/HBM supply.
STMicroelectronics (STM.US) Q3 results mixed, guidance exceeds expectations; AI and satellite communication demand support growth
STMicroelectronics (STM.US) released its Q3 2026 financial report and provided guidance for Q4 that surpassed market expectations, indicating a continued recovery in chip demand.
Crypto prices
More
